Product Description

Drug name  General name: infliximab for injection  Brand name: Leiting  English name: infliximab for injection  Chinese name: Zhusheyong Yingfulixi Dankang  Formula  API: infliximab  Excipients: sucrose, tween 80, sodium dihydrogen phosphate, disodium hydrogen phosphate  Character  This product is a white loose powder and colorless to pale yellow liquid with opalesce after  dissolution. No foreign matter.  Indication  Rheumatoid Arthritis (RA)  This is an anti-RA drug product for disease control in moderate to severe RA patients. This product  can be in combination with methotrexate to reduce signs and symptoms and improve physical  function to prevent disability.  Crohn’s Disease (CD) in adult and children (NLT 6 years old)  For patients with moderately to severely active disease who have had an inadequate response to  conventional therapy, this product can reduce signs and symptoms, induce and maintain clinical  remission, induce the adult mucosal healing, improve life quality and decrease or stop adult using  corticosteroid.  Fistula Crohn’s Disease For patients, this product can reduce the number of enterocutaneous and rectovaginal fistulas,  reduce signs and symptoms and improve life quality.  Ankylosing Spondylitis (AS)  For patients, this product can reduce signs and symptoms, including increase of range of motion,  improve physical function and life quality.  Plaque Psoriasis (Ps)  This product is for treatment of adult patients with chronic severe (i.e., extensive and/or disabling)  plaque psoriasis who are candidates for systemic therapy and when other systemic therapies, such  as methotrexate, cyclosporine and photochemotherapy, are medically less appropriate. This product  can only be used when the doctor can monitor and interview the patients regularly.  Ulcerative Colitis (UC) in adult This product is for treatment of adult patients with moderate to severe ulcerative colitis when other  traditional therapies are medically less appropriate. This product can reduce signs and symptoms,  induce and maintain clinical remission, induce the adult mucosal healing and decrease or stop using  corticosteroid.  Strength  100mg/vial